ProShare Advisors LLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 119 filers reported holding DENALI THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.7%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$501,969
-29.8%
24,332
+0.4%
0.00%0.0%
Q2 2023$714,820
+39.2%
24,223
+8.7%
0.00%0.0%
Q1 2023$513,469
-31.4%
22,286
-17.2%
0.00%
-33.3%
Q4 2022$748,311
+6.9%
26,908
+18.1%
0.00%0.0%
Q3 2022$700,000
+7.2%
22,789
+2.8%
0.00%
+50.0%
Q2 2022$653,000
-36.4%
22,174
-30.4%
0.00%0.0%
Q1 2022$1,026,000
-41.6%
31,881
-19.1%
0.00%
-33.3%
Q4 2021$1,757,000
-12.6%
39,402
-1.1%
0.00%
-50.0%
Q3 2021$2,010,000
-43.5%
39,837
-12.2%
0.01%
-40.0%
Q2 2021$3,558,000
+85.6%
45,362
+35.1%
0.01%
+66.7%
Q1 2021$1,917,000
-29.4%
33,577
+3.5%
0.01%
-40.0%
Q4 2020$2,717,000
+206.0%
32,438
+30.9%
0.01%
+150.0%
Q3 2020$888,000
+44.4%
24,787
-2.5%
0.00%
+33.3%
Q2 2020$615,000
+115.8%
25,424
+56.2%
0.00%
+50.0%
Q1 2020$285,000
-40.0%
16,279
-40.3%
0.00%0.0%
Q4 2019$475,000
-1.2%
27,266
-13.1%
0.00%
-33.3%
Q3 2019$481,000
-29.2%
31,390
-4.0%
0.00%
-25.0%
Q2 2019$679,000
-21.4%
32,689
-12.2%
0.00%
-20.0%
Q1 2019$864,000
+13.1%
37,211
+0.6%
0.01%0.0%
Q4 2018$764,00036,9850.01%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Crestline Management, LP 7,460,732$219,569,00028.65%
ARCH Venture Management, LLC 5,168,749$152,116,00018.54%
Casdin Capital, LLC 1,500,000$44,145,0003.73%
Flagship Pioneering Inc. 2,619,968$77,106,0002.90%
Yiheng Capital Management, L.P. 1,014,684$29,862,0001.71%
SECTORAL ASSET MANAGEMENT INC 202,100$5,948,0001.20%
GILDER GAGNON HOWE & CO LLC 1,956,820$57,589,0001.03%
Artal Group S.A. 600,000$17,658,0000.94%
Temasek Holdings (Private) Ltd 5,369,487$158,024,0020.87%
BRANDYWINE MANAGERS, LLC 9,601$283,0000.69%
View complete list of DENALI THERAPEUTICS INC shareholders